Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression

Journal of Psychiatry and Neuroscience

Volumn 42, Issue 1, 2017, Pages 6-16

  Njau, Stephanie ^a   Joshi, Shantanu H ^a   Espinoza, Randall ^b   Leaver, Amber M ^a   Vasavada, Megha ^a   Marquina, Antonio ^c   Woods, Roger P ^a,b   Narr, Katherine L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; METHOHEXITAL; N ACETYLASPARTIC ACID; SUXAMETHONIUM; BIOLOGICAL MARKER;

ADULT; ANESTHESIA; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTROCONVULSIVE THERAPY; ELECTROCONVULSIVE THERAPY UNIT; FEMALE; FOLLOW UP; HAMILTON DEPRESSION RATING SCALE; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; METABOLITE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROCHEMISTRY; PARALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE THRESHOLD; SIGNAL NOISE RATIO; TREATMENT OUTCOME; TREATMENT RESPONSE; BIPOLAR DISORDER; CEREBROSPINAL FLUID; CINGULATE GYRUS; DIAGNOSTIC IMAGING; LONGITUDINAL STUDY; METABOLISM; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS;

ADULT; BIOMARKERS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MALE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 85007044916     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.150177     Document Type: Article

References (56)

1. World Health Organization. Depression: a public health concern. 2012. Available: www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf.
2. Krishnan V, Nestler EJ. Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 2010;167:1305-20.
3. Phillips ML, Chase H, Sheline Y, et al. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. Am J Psychiatry 2015;172:124-38.
4. Petrides G, Fink M, Husain M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;17:244-53.
5. Husain MM, Rush A, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004;65:485-91.
6. Fosse R, Read J. Electroconvulsive treatment: hypotheses about mechanisms of action. Front Psychiatry 2013;4:94.
7. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65:193-207.
8. Drevets WC, Price J, Furey M. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008;213:93-118.
9. Koenigs M, Grafman J. Prefrontal asymmetry in depression? The long-term effect of unilateral brain lesions. Neurosci Lett 2009; 459:88-90.
10. Rogers MA, Kasai K, Koji M, et al. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res 2004;50:1-11.
11. Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008;13:663.
12. Lorenzetti V, Allen N, Fornito A, et al. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord 2009;117:1-17.
13. Liao Y, Huang X, Wu Q, et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 2013;38:49-56.
14. Seminowicz DA, Mayberg H, McIntosh A, et al. Limbic–frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004;22:409-18.
15. Fales CL, Barch D, Rundle M, et al. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry 2008;63:377-84.
16. Kemp AH, Gordon E, Rush A, et al. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr 2008;13:1066-86.
17. Joshi SH, Espinoza R, Pirnia T, et al. Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biol Psychiatry 2016;79:282-92.
18. Zhang J, Narr K, Woods R, et al. Glutamate normalization with ECT treatment response in major depression. Mol Psychiatry 2013; 18:268.
19. Lyden H, Espinoza R, Pirnia T, et al. Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Transl Psychiatry 2014;4:e380.
20. Rao NP, Venkatasubramanian G, Gangadhar B. Proton magnetic resonance spectroscopy in depression. Indian J Psychiatry 2011;53:307.
21. Auer DP, Pütz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-13.
22. Pfleiderer B, Michael N, Erfurth A, et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003; 122:185-92.
23. Block W, Träber F, von Widdern O, et al. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol 2009;12:415-22.
24. Mu J, Xie P, Yang Z-S, et al. 1 H magnetic resonance spectroscopy study of thalamus in treatment resistant depressive patients. Neurosci Lett 2007;425:49-52.
25. Vythilingam M, Charles HC, Tupler LA, et al. Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 2003;54:744-50.
26. Ende G, Braus D, Walter S, et al. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000;57: 937-43.
27. Michael N, Erfurth A, Ohrmann P, et al. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 2003;28:720-5.
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
29. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
30. Hess AT, Tisdall D, Andronesi O, et al. Real‐time motion and B0 corrected single voxel spectroscopy using volumetric navigators. Magn Reson Med 2011;66:314-23.
31. Tisdall MD, Hess A, Reuter M, et al. Volumetric navigators for prospective motion correction and selective reacquisition in neuroanatomical MRI. Magn Reson Med 2012;68:389-99.
32. Joshi S, Njau S, Marquina A, et al. Denoising of MR spectroscopy signals using total variation and iterative Gauss-Siedel gradient updates. IEEE International Symposium on Biomedical Imaging; 2015 Apr 16-19; New York, New York.
33. Shattuck DW, Leahy R. BrainSuite: an automated cortical surface identification tool. Med Image Anal 2002;6:129-42.
34. Gussew A, Erdtel M, Rzanny R, et al. Absolute quantitation of brain metabolites with respect to the CSF fraction in 1H-MR spectroscopic volumes. MAGMA 2012;25:321-33.
35. Kellner CH, Greenberg R, Murrough J, et al. ECT in treatment-resistant depression. Am J Psychiatry 2012;169:1238-44.
36. Hasler G, van der Veen J, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007;64:193-200.
37. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012;62:63-77.
38. Gillin JC, Buchsbaum M, Wu J, et al. Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging. Depress Anxiety 2001;14:37-49.
39. Mayberg HS, Lozano A, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-60.
40. Nobler MS, Oquendo M, Kegeles L, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry 2001;158:305-8.
41. Mayberg HS, Liotti M, Brannan S, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:675-82.
42. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008;213:93-118.
43. Kemp AH, Gordon E, Rush A, et al. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr 2008;13:1066-86.
44. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010;35:192-216.
45. Clark CP, Brown G, Archibald S, et al. Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression? Psychiatry Res 2006;146:43-51.
46. Nieuwenhuys R, Voogd J, Van Huijzen C. The human central nervous system: a synopsis and atlas. 4th ed. Berlin: New York Springer; 2007.
47. Yildiz-Yesiloglu A, Ankerst D. Review of 1 H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 2006;147:1-25.
48. Sheline YI, Mittler B, Mintun M. The hippocampus and depression. Eur Psychiatry 2002;(Suppl 3):300-5.
49. Joshi SH, Espinoza R, Pirnia T, et al. Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biol Psychiatry. In press.
50. Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: a road to remission? Science 2012;338:72-5.
51. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003;28:941-53.
52. Chen F, Madsen T, Wegener G, et al. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur Neuropsychopharmacol 2009;19:329-38.
53. Schmidt HD, Duman R. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007;18: 391-418.
54. Lledo P-M, Alonso M, Grubb M. Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci 2006;7: 179-93.
55. Cuthbert BN. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014;13:28-35.
56. Oldfield RC. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971;9:97-113.